Pediatrix Medical Group, Inc. (NYSE:MD) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned an average recommendation of “Hold” from the four research firms that are currently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation. The average 12 month target price among analysts that have covered the stock in the last year is $9.38.

Several equities research analysts recently issued reports on MD shares. Mizuho cut their target price on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Jefferies Financial Group reduced their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Finally, Truist Financial reaffirmed a “hold” rating and set a $10.00 price objective on shares of Pediatrix Medical Group in a research report on Wednesday, May 15th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of MD. Virtu Financial LLC acquired a new position in shares of Pediatrix Medical Group in the first quarter valued at approximately $124,000. Tidal Investments LLC acquired a new position in Pediatrix Medical Group in the 1st quarter valued at approximately $442,000. Price T Rowe Associates Inc. MD increased its position in Pediatrix Medical Group by 4.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 87,369 shares of the company’s stock valued at $877,000 after acquiring an additional 3,669 shares during the period. Vanguard Group Inc. raised its stake in shares of Pediatrix Medical Group by 1.6% during the first quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock valued at $105,892,000 after acquiring an additional 164,333 shares during the last quarter. Finally, ProShare Advisors LLC lifted its holdings in shares of Pediatrix Medical Group by 7.4% during the first quarter. ProShare Advisors LLC now owns 16,937 shares of the company’s stock worth $170,000 after purchasing an additional 1,167 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

MD opened at $7.46 on Monday. The company has a market capitalization of $627.76 million, a price-to-earnings ratio of -8.78, a P/E/G ratio of 1.43 and a beta of 1.58. The business’s 50-day moving average price is $8.95 and its two-hundred day moving average price is $9.13. Pediatrix Medical Group has a 1 year low of $7.26 and a 1 year high of $15.02. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.72 and a quick ratio of 1.72.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.02. The company had revenue of $496.44 million for the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The firm’s revenue was down 3.4% compared to the same quarter last year. During the same period last year, the company earned $0.46 earnings per share. Equities analysts expect that Pediatrix Medical Group will post 1.12 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.